Pionier der Genbearbeitung fordert große Investitionen in die Crispr-Technologie

„Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, according to its co-discoverer.“